Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0031 | 0.4775 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.2319 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.2319 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.2319 | 0.2319 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.2319 | 0.2319 |
Brugia malayi | hypothetical protein | 0.0025 | 0.2319 | 0.2319 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.2319 | 0.2319 |
Leishmania major | DNA polymerase eta, putative | 0.0031 | 0.4775 | 0.4775 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.2319 | 0.5 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.2319 | 0.2319 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.2319 | 0.2319 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0031 | 0.4775 | 0.4775 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 32.6427 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.